Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

118 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Platelet transfusion in neonatal intensive care units of 22 European countries: a prospective observational study.
Houben NAM, Lopriore E, Fijnvandraat K, Caram-Deelder C, Carrascosa MA, Beuchée A, Brække K, Cardona F, Debeer A, Domingues S, Ghirardello S, Grizelj R, Hadžimuratović E, Heiring C, Krivec JL, Malý J, Matasova K, Moore CM, Muehlbacher T, Szabó M, Szczapa T, Zaharie G, de Jager J, Reibel-Georgi NJ, New HV, Stanworth SJ, Deschmann E, Roehr CC, Dame C, le Cessie S, van der Bom J, Fustolo-Gunnink S; INSPIRE Study Group. Houben NAM, et al. Lancet Reg Health Eur. 2024 Oct 10;47:101086. doi: 10.1016/j.lanepe.2024.101086. eCollection 2024 Dec. Lancet Reg Health Eur. 2024. PMID: 39669406 Free PMC article.
Statistical analysis plan for the FiO2-C trial: effects of closed-loop automatic control of the inspiratory fraction of oxygen (FiO2-C) on outcomes of extremely preterm infants-a randomized-controlled parallel group multicentre trial for safety and efficacy.
König J, Stauch A, Engel C, Urschitz MS, Franz AR; FiO2-C study group. König J, et al. Trials. 2024 Nov 12;25(1):756. doi: 10.1186/s13063-024-08615-7. Trials. 2024. PMID: 39533330 Free PMC article.
Red Blood Cell Transfusion in European Neonatal Intensive Care Units, 2022 to 2023.
Houben NAM, Fustolo-Gunnink S, Fijnvandraat K, Caram-Deelder C, Carrascosa MA, Beuchée A, Brække K, Cardona F, Debeer A, Domingues S, Ghirardello S, Grizelj R, Hadžimuratovic E, Heiring C, Krivec JL, Malý J, Matasova K, Moore CM, Muehlbacher T, Szabó M, Szczapa T, Zaharie G, de Jager J, Reibel-Georgi NJ, New HV, Stanworth SJ, Deschmann E, Roehr CC, Dame C, le Cessie S, van der Bom J, Lopriore E; International Neonatal Transfusion Point Prevalence Study Group. Houben NAM, et al. JAMA Netw Open. 2024 Sep 3;7(9):e2434077. doi: 10.1001/jamanetworkopen.2024.34077. JAMA Netw Open. 2024. PMID: 39298172 Free PMC article.
New alternatives to holder pasteurization in processing donor milk in human milk banks.
Moro GE, Girard M, Peila C, Garcia N, Escuder-Vieco D, Keller K, Cassidy T, Bertino E, Boquien CY, Buffin R, Calvo J, Gaya A, Gebauer C, Lamireau D, Lembo D, Picaud JC, Wesolowska A, Arslanoglu S, Cavallarin L, Giribaldi M. Moro GE, et al. Among authors: gebauer c. Front Nutr. 2024 Jun 26;11:1409381. doi: 10.3389/fnut.2024.1409381. eCollection 2024. Front Nutr. 2024. PMID: 38988859 Free PMC article. Review.
Early postnatal high-dose fat-soluble enteral vitamin A supplementation for moderate or severe bronchopulmonary dysplasia or death in extremely low birthweight infants (NeoVitaA): a multicentre, randomised, parallel-group, double-blind, placebo-controlled, investigator-initiated phase 3 trial.
Meyer S, Bay J, Franz AR, Ehrhardt H, Klein L, Petzinger J, Binder C, Kirschenhofer S, Stein A, Hüning B, Heep A, Cloppenburg E, Muyimbwa J, Ott T, Sandkötter J, Teig N, Wiegand S, Schroth M, Kick A, Wurm D, Gebauer C, Linnemann K, Kittel J, Wieg C, Kiechl-Kohlendorfer U, Schmidt S, Böttger R, Thomas W, Brevis Nunez F, Stockmann A, Kriebel T, Müller A, Klotz D, Morhart P, Nohr D, Biesalski HK, Giannopoulou EZ, Hilt S, Poryo M, Wagenpfeil S, Haiden N, Ruckes C, Ehrlich A, Gortner L; NeoVitaA trial investigators. Meyer S, et al. Among authors: gebauer c. Lancet Respir Med. 2024 Jul;12(7):544-555. doi: 10.1016/S2213-2600(24)00073-0. Epub 2024 Apr 18. Lancet Respir Med. 2024. PMID: 38643780 Clinical Trial.
Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial.
Tuttle KR, Hauske SJ, Canziani ME, Caramori ML, Cherney D, Cronin L, Heerspink HJL, Hugo C, Nangaku M, Rotter RC, Silva A, Shah SV, Sun Z, Urbach D, de Zeeuw D, Rossing P; ASi in CKD group. Tuttle KR, et al. Lancet. 2024 Jan 27;403(10424):379-390. doi: 10.1016/S0140-6736(23)02408-X. Epub 2023 Dec 15. Lancet. 2024. PMID: 38109916 Clinical Trial.
118 results